Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Shares Repurchased (2020 - 2024)

Integra Lifesciences Holdings (IART) has disclosed Shares Repurchased for 5 consecutive years, with $2.5 million as the latest value for Q4 2024.

  • Quarterly Shares Repurchased changed N/A to $2.5 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, down 95.29% year-over-year, with the annual reading at $221000.0 for FY2025, 99.58% down from the prior year.
  • Shares Repurchased hit $2.5 million in Q4 2024 for Integra Lifesciences Holdings, down from $50.0 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $150.0 million in Q1 2023 to a low of $2.5 million in Q4 2024.
  • Historically, Shares Repurchased has averaged $92.1 million across 4 years, with a median of $112.5 million in 2020.
  • Biggest YoY gain for Shares Repurchased was 20.0% in 2023; the steepest drop was 20.0% in 2023.
  • Year by year, Shares Repurchased stood at $100.0 million in 2020, then rose by 25.0% to $125.0 million in 2022, then changed by 0.0% to $125.0 million in 2023, then crashed by 98.02% to $2.5 million in 2024.
  • Business Quant data shows Shares Repurchased for IART at $2.5 million in Q4 2024, $50.0 million in Q2 2024, and $125.0 million in Q3 2023.